Acnegen contains isotretinoin, also known as 13 cis retinoic acid, a systemic retinoid derived from vitamin A. Acnegen is an international isotretinoin brand used for severe forms of acne, while isotretinoin itself is an established prescription treatment for severe nodular, inflammatory, and treatment resistant acne.
Isotretinoin addresses several of the major biological processes involved in acne development. One of its most significant effects is the suppression of sebaceous gland activity and sebum production. Excessive sebum contributes to blocked pores and creates an environment that promotes inflammatory acne. By substantially reducing oil production, isotretinoin targets an important underlying factor in severe acne.
Isotretinoin also helps normalize follicular keratinization and skin cell turnover, reducing the accumulation of cells within pores that can lead to blackheads, whiteheads, and inflammatory lesions. These combined effects on sebum production, follicular obstruction, and inflammation distinguish isotretinoin from acne treatments that target only one component of the condition.
Oral isotretinoin is generally reserved for severe or recalcitrant acne that has not responded adequately to conventional therapy, including systemic antibiotics and topical treatments. Canadian prescribing information similarly identifies isotretinoin for severe nodular and/or inflammatory acne and other serious forms of treatment resistant acne.
This product provides:
- Active Ingredient: Isotretinoin
- Strength: 20mg
- Quantity: 30 Tablets
- Drug Class: Systemic Retinoid
- Primary Use: Severe and treatment resistant acne
Isotretinoin is a prescription medication with significant safety requirements. The most important risk is pregnancy: isotretinoin is highly teratogenic and is contraindicated during pregnancy because fetal exposure can cause severe, potentially life threatening birth defects.
Common treatment effects include pronounced dryness of the lips and skin, dry eyes, nasal dryness, and increased skin sensitivity. Isotretinoin can also affect serum lipid levels and liver function, so laboratory monitoring may be required before and during treatment depending on the patient and prescribing protocol.
Concurrent use with tetracycline class antibiotics and additional vitamin A products requires particular caution because of the potential for clinically significant adverse effects. Treatment dose and duration should therefore be determined and monitored by a qualified healthcare professional.
